Bonus & Incentive Agreements in the Pharmaceuticals Industry

2,392 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (2 contracts)
Acasti Pharma Inc. (2)
ACELRX PHARMACEUTICALS INC (20)
Acer Therapeutics Inc. (10)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (5)
Acreage Holdings, Inc. (4)
ACURA PHARMACEUTICALS, INC (2)
Adamis Pharmaceuticals Corp (14)
ADIAL PHARMACEUTICALS, INC. (9)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (6)
AERIE PHARMACEUTICALS INC (6)
Aerpio Pharmaceuticals, Inc. (11)
AGILE THERAPEUTICS INC (5)
Akers Biosciences, Inc. (9)
Akorn (6)
ALDER BIOPHARMACEUTICALS INC (9)
Alexza Pharmaceuticals Inc. (9)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (18)
Allergan, plc (9)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (3)
Amag Pharmaceuticals (20)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (4)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (3)
AN2 Therapeutics, Inc. (5)
Anacor Pharmaceuticals, Inc. (9)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (11)
ANI Pharma Inc (24)
Anthera Pharmaceuticals Inc (7)
Apimeds Pharmaceuticals US, Inc. (1)
APP Pharmaceuticals, Inc. (1)
APRICUS BIOSCIENCES, INC. (4)
Aquestive Therapeutics, Inc. (5)
Aralez Pharmaceuticals Inc. (11)
ARIAD PHARMACEUTICALS INC (11)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
ARVINAS, INC. (7)
Assertio Holdings, Inc. (5)
Assertio Therapeutics, Inc (22)
ATAI Life Sciences B.V. (6)
Atea Pharmaceuticals, Inc. (6)
Athira Pharma, Inc. (9)
Auspex Pharmaceuticals, Inc. (6)
AUXILIUM PHARMACEUTICALS INC (5)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (4)
AVANIR PHARMACEUTICALS, INC. (7)
AVENUE THERAPEUTICS, INC. (2)
Axsome Therapeutics, Inc. (7)
AYTU BIOSCIENCE, INC (1)
Bakhu Holdings, Corp. (1)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (27)
BENTLEY PHARMACEUTICALS INC (5)
Bespoke Extracts, Inc. (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (14)
Biofrontera Inc. (6)
Biohaven Ltd. (1)
BioPharmX Corp (5)
Blue Water Acquisition Corp. (2)
Braeburn Pharmaceuticals, Inc. (1)
Bristol-Myers Squibb (112)
CADENCE PHARMACEUTICALS INC (10)
Cancer Prevention Pharmaceuticals, Inc. (6)
Cannabics Pharmaceuticals Inc. (1)
Canopy Growth Corp (9)
Cara Therapeutics, Inc. (4)
CARDAX, INC. (1)
CASSAVA SCIENCES INC (10)
Catalent Inc (42)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (15)
CERAGENIX PHARMACEUTICALS, INC. (1)
Cerecor Inc. (6)
Charlotte's Web Holdings, Inc. (1)
CHIASMA, INC (2)
CHINA PHARMA HOLDINGS, INC. (3)
CinCor Pharma, Inc. (1)
Cingulate Inc. (4)
Citius Pharmaceuticals, Inc. (3)
Clearside Biomedical, Inc. (7)
Clever Leaves Holdings Inc. (6)
CLS Holdings USA, Inc. (2)
Cocrystal Pharma, Inc. (1)
COGNITION THERAPEUTICS INC (7)
COLLEGIUM PHARMACEUTICAL, INC (14)
CoLucid Pharmaceuticals, Inc. (7)
Columbia Care Inc. (2)
Context Therapeutics Inc. (3)
Corcept Therapeutics Incorporated (6)
CorMedix Inc. (6)
COSMO VENTURES INC (1)
CPEX Pharmaceuticals, Inc. (1)
Cronos Group Inc. (3)
CUBIST PHARMACEUTICALS INC (29)
CUMBERLAND PHARMACEUTICALS INC (10)
Cure Pharmaceutical Holding Corp. (4)
CymaBay Therapeutics, Inc. (4)
Cyteir Therapeutics, Inc. (9)
Dermata Therapeutics, Inc. (6)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (4)
EASTON PHARMACEUTICALS INC. (1)
Edgewise Therapeutics, Inc. (4)
Egalet Corp (12)
Elanco Animal Health Inc (9)
ELITE PHARMACEUTICALS INC (1)
Elixir Pharmaceuticals, Inc. (5)
Eloxx Pharmaceuticals, Inc. (10)
ENCYSIVE PHARMACEUTICALS INC (1)
Endo International plc (39)
Endo Pharmaceuticals Solutions Inc. (4)
EPIX Pharmaceuticals, Inc. (6)
Eton Pharmaceuticals, Inc. (6)
Evofem Biosciences, Inc. (13)
Evoke Pharma Inc (5)
Evolus, Inc. (7)
Exactus, Inc. (7)
EYEGATE PHARMACEUTICALS INC (8)
EYENOVIA, INC. (6)
EyePoint Pharmaceuticals, Inc. (25)
EYETECH PHARMACEUTICALS INC (2)
Foamix Pharmaceuticals Ltd. (3)
Fulcrum Therapeutics, Inc. (11)
GB SCIENCES INC (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (4)
Green Thumb Industries Inc. (3)
GUILFORD PHARMACEUTICALS INC (2)
GW PHARMACEUTICALS PLC (2)
Harmony Biosciences Holdings, Inc. (7)
HARROW HEALTH, INC. (11)
Horizon Pharma plc (13)
Hoth Therapeutics, Inc. (1)
IDENIX PHARMACEUTICALS INC (8)
Ikena Oncology, Inc. (2)
IMARA Inc. (12)
INNOVATE BIOPHARMACEUTICALS, INC. (12)
Innoviva, Inc. (33)
INSPIRE PHARMACEUTICALS INC (5)
Intersect ENT, Inc. (10)
Intra-Cellular Therapies, Inc. (16)
ISTA PHARMACEUTICALS INC (3)
Iterum Therapeutics plc (11)
Jaguar Health, Inc. (5)
JAVELIN PHARMACEUTICALS, INC (2)
Jazz Pharmaceuticals plc (66)
Johnson & Johnson (9)
Journey Medical Corp (1)
JUNIPER PHARMACEUTICALS INC (9)
Jushi Holdings Inc. (2)
Kala Pharmaceuticals, Inc. (12)
Kaleido Biosciences, Inc. (3)
Kannalife Inc (2)
Kaya Holdings, Inc. (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (19)
KOLLTAN PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Lexaria Bioscience Corp. (1)
Lilly (Eli) & Co. (23)
LIPELLA PHARMACEUTICALS INC (7)
Lipocine Inc. (5)
Liquidia Corp (9)
Liquidia Technologies Inc (1)
Longboard Pharmaceuticals, Inc. (9)
Lowell Farms Inc. (1)
Lumena Pharmaceuticals, Inc. (1)
Lyra Therapeutics, Inc. (7)
Mallinckrodt (38)
MAP Pharmaceuticals, Inc. (2)
Marijuana Co of America, Inc. (1)
MARINUS PHARMACEUTICALS INC (17)
Medicine Man Technologies, Inc. (8)
MedMen Enterprises, Inc. (1)
Melt Pharmaceuticals, Inc. (5)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (16)
Merck (69)
MiddleBrook Pharmaceuticals, Inc. (1)
Milestone Pharmaceuticals Inc. (6)
MILLENNIUM PHARMACEUTICALS INC (2)
Mind Medicine (MindMed) Inc. (2)
MIRA PHARMACEUTICALS, INC. (2)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (17)
MYnd Analytics, Inc. (3)
MyoKardia Inc (4)
Nabriva Therapeutics plc (13)
NEKTAR THERAPEUTICS (24)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (11)
NEW RIVER PHARMACEUTICALS INC (1)
NEXIEN BIOPHARMA, INC. (2)
NGM BIOPHARMACEUTICALS INC (5)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (7)
NPS PHARMACEUTICALS INC (7)
NUCRYST Pharmaceuticals Corp. (4)
OCULAR THERAPEUTIX, INC (13)
OMEROS CORP (4)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (6)
Onconova Therapeutics, Inc. (4)
One World Pharma, Inc. (3)
ONYX PHARMACEUTICALS INC (12)
OPIANT PHARMACEUTICALS, INC. (6)
OPTIMER PHARMACEUTICALS INC (5)
OptiNose, Inc. (7)
ORAMED PHARMACEUTICALS INC. (4)
Organon & Co. (7)
OSCIENT PHARMACEUTICALS CORP (2)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (9)
OTONOMY, INC. (4)
Pacira Pharmaceuticals, Inc. (14)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (4)
Paratek Pharmaceuticals, Inc. (13)
PaxMedica, Inc. (5)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (7)
Perrigo (43)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (3)
Pfizer (10)
Phathom Pharmaceuticals, Inc. (11)
Phibro Animal Health Corporation (3)
PLIANT THERAPEUTICS, INC. (3)
PLx Pharma Inc. (5)
PONIARD PHARMACEUTICALS, INC. (11)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (3)
Prestige Brands Holdings Inc (4)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (3)
Provention Bio, Inc. (3)
Pulmatrix, Inc. (6)
QUANTA INC (1)
QUARK PHARMACEUTICALS INC (3)
QUATRX PHARMACEUTICALS CO (1)
QUESTCOR PHARMACEUTICALS INC (3)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (1)
Rain Therapeutics Inc. (9)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (3)
Recro Pharma, Inc. (9)
Reliant Pharmaceuticals, Inc. (7)
RELMADA THERAPEUTICS, INC. (11)
RespireRx Pharmaceuticals Inc. (16)
resTORbio, Inc. (20)
Revance Therapeutics, Inc. (21)
Rib-X Pharmaceuticals, Inc. (10)
ROCK CREEK PHARMACEUTICALS, INC. (7)
Roivant Sciences Ltd. (9)
Royalty Pharma plc (2)
Sagent Pharmaceuticals, Inc. (5)
SALIX PHARMACEUTICALS LTD (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (2)
Satsuma Pharmaceuticals, Inc. (7)
SAVIENT PHARMACEUTICALS INC (4)
SCICLONE PHARMACEUTICALS INC (13)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (3)
SCYNEXIS INC (4)
SenesTech, Inc. (6)
Shuttle Pharmaceuticals, Inc. (1)
Sienna Biopharmaceuticals, Inc. (11)
SIGA TECHNOLOGIES INC (5)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (9)
Supernus Pharmaceuticals, Inc. (13)
SYNERGY PHARMACEUTICALS, INC. (1)
TAPESTRY PHARMACEUTICALS, INC (3)
Targeted Medical Pharma, Inc. (5)
Tarsus Pharmaceuticals, Inc. (2)
Telomir Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (4)
Terns Pharmaceuticals, Inc. (8)
Terra Tech Corp. (7)
TerrAscend Corp. (1)
TETRALOGIC PHARMACEUTICALS CORP (4)
TETRAPHASE PHARMACEUTICALS INC (7)
TEVA PHARMACEUTICAL INDUSTRIES LTD (19)
TFF Pharmaceuticals, Inc. (1)
THAR PHARMACEUTICALS INC (2)
The Medicines Company (16)
TherapeuticsMD, Inc. (2)
Theravance Biopharma, Inc. (9)
Theseus Pharmaceuticals, Inc. (2)
Tilray, Inc. (6)
TILT Holdings Inc. (4)
TITAN PHARMACEUTICALS INC (7)
Trevi Therapeutics, Inc. (4)
Tricida, Inc. (3)
Trulieve Cannabis Corp. (2)
Upjohn Inc (8)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (5)
VALEANT PHARMACEUTICALS INTERNATIONAL (2)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (8)
Ventyx Biosciences, Inc. (4)
Verano Holdings Corp. (4)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (4)
Viamet Pharmaceuticals Holdings LLC (3)
VION PHARMACEUTICALS INC (2)
VioQuest Pharmaceuticals, Inc. (2)
Vireo Health International, Inc. (3)
Virpax Pharmaceuticals, Inc. (8)
Vitae Pharmaceuticals, Inc (4)
Vitality Biopharma, Inc. (4)
VIVUS INC (3)
Wave Life Sciences Ltd. (17)
Winston Pharmaceuticals, Inc. (1)
XANODYNE PHARMACEUTICALS INC (4)
XERIS PHARMACEUTICALS INC (3)
Zoetis (9)
ZOGENIX, INC. (11)
Zynerba Pharmaceuticals, Inc. (12)

Recent Contracts

First Amendment to the TNF Pharmaceuticals, Inc. 2021 Equity Incentive Plan (Akers Biosciences, Inc., Filed With SEC on November 26, 2024)
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Executives and Non-Employee Directors) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation... (Axsome Therapeutics, Inc., Filed With SEC on November 12, 2024)
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Non-Executives) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan (Axsome Therapeutics, Inc., Filed With SEC on November 12, 2024)
Axsome Therapeutics, Inc. Form of Stock Option Agreement pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan (Axsome Therapeutics, Inc., Filed With SEC on November 12, 2024)
Amendment No. 6 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan (ADIAL PHARMACEUTICALS, INC., Filed With SEC on November 12, 2024)
AMENDMENT NO. 3 TO THE GREEN THUMB INDUSTRIES INC. 2018 STOCK AND INCENTIVE PLAN (Green Thumb Industries Inc., Filed With SEC on November 8, 2024)
ANI Pharmaceuticals, Inc Amended and Restated 2022 Stock Incentive Plan Notice of Restric (ANI Pharma Inc, Filed With SEC on November 8, 2024)
ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan Sub-Plan for U.K. Employees (ANI Pharma Inc, Filed With SEC on November 8, 2024)
Acasti Pharma Inc. 2024 Equity Incentive Plan (Acasti Pharma Inc., Filed With SEC on September 30, 2024)
Apimeds Pharmaceuticals US, Inc. 2024 Equity Incentive Plan (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Form of Retention Bonus Letter (Aerpio Pharmaceuticals, Inc., Filed With SEC on September 19, 2024)
CalciMedica, Inc. 2023 Equity Incentive Plan (GRAYBUG VISION, INC., Filed With SEC on August 27, 2024)
Edgewise Therapeutics, Inc. 2024 Inducement Equity Incentive Plan and related forms of stock option and restricted stock unit agreements (Edgewise Therapeutics, Inc., Filed With SEC on August 12, 2024)
Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended (Wave Life Sciences Ltd., Filed With SEC on August 12, 2024)
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended (NEKTAR THERAPEUTICS, Filed With SEC on August 9, 2024)
Form of Global Terms for 2024 Restricted Stock Unit Award Under the Organon & Co. 2021 Incentive Stock Plan (Cash Default) (Organon & Co., Filed With SEC on August 7, 2024)
Form of Global Terms for 2024 Restricted Stock Unit Award Under the Organon & Co. 2021 Incentive Stock Plan (Stock Default) (Organon & Co., Filed With SEC on August 7, 2024)
Form of Global Terms for 2024 Performance Stock Unit Award Under the Organon & Co. 2021 Incentive Stock Plan (Organon & Co., Filed With SEC on August 7, 2024)
Form of Global Terms for 2024 Non-Qualified Stock Option Grants Under the Organon & Co. 2021 Incentive Stock Plan (Organon & Co., Filed With SEC on August 7, 2024)
Mallinckrodt plc Amended and Restated Long-Term Transaction Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Form of Amended and Restated Performance Unit Award for Directors under the Mallinckrodt plc 2024 Stock and Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Form of Amended and Restated Performance Unit Award for the CEO under the Mallinckrodt plc 2024 Stock and Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Form of Amended and Restated Performance Unit Award for Officers under the Mallinckrodt plc 2024 Stock and Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Form of Amended and Restated Restricted Unit Award for Directors under the Mallinckrodt plc 2024 Stock and Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Form of Amended and Restated Restricted Unit Award for the CEO under the Mallinckrodt plc 2024 Stock and Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Form of Amended and Restated Restricted Unit Award for Officers under the Mallinckrodt plc 2024 Stock and Incentive Plan (Mallinckrodt, Filed With SEC on August 6, 2024)
Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (as amended and restated May 23, 2024) (Longboard Pharmaceuticals, Inc., Filed With SEC on August 1, 2024)
Form of Non-Employee Directors Restricted Stock Unit Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017) (SIGA TECHNOLOGIES INC, Filed With SEC on August 1, 2024)
Form of Performance Stock Unit Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017) (SIGA TECHNOLOGIES INC, Filed With SEC on August 1, 2024)
Form of Restricted Stock Unit Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017) (SIGA TECHNOLOGIES INC, Filed With SEC on August 1, 2024)
Form of Stock Option Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017) (SIGA TECHNOLOGIES INC, Filed With SEC on August 1, 2024)
Amendment to the Virpax Pharmaceuticals, Inc. 2022 Equity Incentive Plan to Increase Evergreen Provision Percentage (Virpax Pharmaceuticals, Inc., Filed With SEC on July 30, 2024)
Amendment to the Virpax Pharmaceuticals, Inc. 2022 Equity Incentive Plan to Increase in Authorized Shares (Virpax Pharmaceuticals, Inc., Filed With SEC on July 30, 2024)
SenesTech, Inc. 2018 Equity Incentive Plan, as amended (SenesTech, Inc., Filed With SEC on July 15, 2024)
Elite Pharmaceuticals, Inc. Restated 2014 Equity Incentive Plan (ELITE PHARMACEUTICALS INC, Filed With SEC on July 1, 2024)
Amendment to the Avenue Therapeutics, Inc. 2015 Incentive Plan (AVENUE THERAPEUTICS, INC., Filed With SEC on June 26, 2024)
Amendment to the Journey Medical Corporation 2015 Stock Incentive Plan (Journey Medical Corp, Filed With SEC on June 25, 2024)
Amended and Restated 2020 Equity Incentive Plan (ACELRX PHARMACEUTICALS INC, Filed With SEC on June 24, 2024)
EyePoint Pharmaceuticals, Inc. Amendment No 1. to 2023 Long-Term Incentive Plan (EyePoint Pharmaceuticals, Inc., Filed With SEC on June 21, 2024)
Amended and Restated 2020 Equity Incentive Plan (IMARA Inc., Filed With SEC on June 18, 2024)